v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash Flows from Operating Activities      
Net Loss from Operations $ (5,255,283) $ (9,504,892)  
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:      
Depreciation 283,528 328,808  
Non-Cash Lease Expenses 131,068 217,635  
Impairments 627,480  
Foreign Transaction (Gain) Loss (108,943) 1,409,102  
Unrealized Loss (Gain) on Securities Investment 1,823,043 (280,908)  
Unrealized Loss on Securities Investment - Related Party 748,601 3,801,655  
Realized Loss on Securities Investment 447,599 180,096  
Loss on Equity Method Investment 106,452 631,568  
Changes in Operating Assets and Liabilities, net of acquisitions      
Real Estate Reimbursement Receivable 38,700 582,500  
Account Receivables 421 (15,360)  
Other Receivable - Related Parties (12,000)  
Prepaid Expense 76,158 53,214  
Deposits (6,429) (16,357)  
Trading Securities 3,230,148 (937,705)  
Inventory (1,496) (1,007)  
Accounts Payable and Accrued Expenses (2,813,045) (617,960)  
Deferred Revenue 14,872  
Operating Lease Liabilities (191,559) (216,895)  
Net Cash Used in Operating Activities (1,491,037) (3,756,154)  
Cash Flows from Investing Activities      
Purchase of Fixed Assets (6,870) (61,244)  
Purchase of Investment Securities (14,907)  
Proceeds from Sale of Equity Security Investment of a Related Party 98,634  
Issuing Loan Receivable - Related Party (3,510,278) (479,297)  
Collection of Loan Receivable - Related Party 775,961 79,036  
Net Cash Used in Investing Activities (2,657,460) (461,505)  
Cash Flows from Financing Activities      
Proceeds from Common Stock Issuance 2,613,526  
Borrowing from a Commercial Loan 4,816  
Repayment to Notes Payable (10,968) (280,074)  
Net Cash (Used in) Provided by Financing Activities (6,152) 2,333,452  
Net Decrease in Cash and Cash Equivalents and Restricted Cash (4,154,649) (1,884,207)  
Effects of Foreign Exchange Rates on Cash and Cash Equivalents 340,287 24,744  
Cash and Cash Equivalents and Restricted Cash - Beginning of Period 25,292,972 28,183,726 $ 28,183,726
Cash and Cash Equivalents and Restricted Cash- End of Period 21,478,610 26,324,263 $ 25,292,972
Cash 21,478,610 25,194,810  
Restricted Cash 1,129,453  
Total Cash and Restricted Cash 21,478,610 26,324,263  
Supplementary Cash Flow Information      
Cash Paid for Interest 1,035 992  
Cash Paid for Taxes 42,948  
Supplemental Disclosure of Non-Cash Investing and Financing Activities      
Initial Recognition of ROU / Lease Liability 132,044  
Gain from DSS Warrants and Convertible Notes $ 3,002,389 $ 87,131